Your browser doesn't support javascript.
loading
Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial.
Rohaan, Maartje W; Stahlie, Emma H A; Franke, Viola; Zijlker, Lisanne P; Wilgenhof, Sofie; van der Noort, Vincent; van Akkooi, Alexander C J; Haanen, John B A G.
Afiliação
  • Rohaan MW; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.
  • Stahlie EHA; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.
  • Franke V; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.
  • Zijlker LP; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.
  • Wilgenhof S; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.
  • van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.
  • van Akkooi ACJ; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.
  • Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. j.haanen@nki.nl.
BMC Cancer ; 22(1): 851, 2022 Aug 04.
Article em En | MEDLINE | ID: mdl-35927710

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Produtos Biológicos / Terapia Viral Oncolítica / Nivolumabe / Melanoma Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Produtos Biológicos / Terapia Viral Oncolítica / Nivolumabe / Melanoma Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda